HRP20010263B1 - Sertraline oral concentrate - Google Patents

Sertraline oral concentrate

Info

Publication number
HRP20010263B1
HRP20010263B1 HR20010263A HRP20010263A HRP20010263B1 HR P20010263 B1 HRP20010263 B1 HR P20010263B1 HR 20010263 A HR20010263 A HR 20010263A HR P20010263 A HRP20010263 A HR P20010263A HR P20010263 B1 HRP20010263 B1 HR P20010263B1
Authority
HR
Croatia
Prior art keywords
oral concentrate
sertraline oral
sertraline
concentrate
oral
Prior art date
Application number
HR20010263A
Other languages
English (en)
Inventor
Jane Harper Nancy
Ramchandra Ranade Gautam
Mckowan Welch Willard
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22298286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010263(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HRP20010263A2 publication Critical patent/HRP20010263A2/hr
Publication of HRP20010263B1 publication Critical patent/HRP20010263B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20010263A 1998-10-13 2001-04-10 Sertraline oral concentrate HRP20010263B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10402498P 1998-10-13 1998-10-13
PCT/IB1999/001571 WO2000021521A2 (en) 1998-10-13 1999-09-22 Sertraline oral concentrate

Publications (2)

Publication Number Publication Date
HRP20010263A2 HRP20010263A2 (en) 2002-06-30
HRP20010263B1 true HRP20010263B1 (en) 2005-04-30

Family

ID=22298286

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010263A HRP20010263B1 (en) 1998-10-13 2001-04-10 Sertraline oral concentrate

Country Status (45)

Country Link
EP (1) EP1121107B1 (no)
JP (1) JP3792514B2 (no)
KR (1) KR100417200B1 (no)
CN (1) CN1184962C (no)
AP (1) AP2001002119A0 (no)
AR (1) AR014082A1 (no)
AT (1) ATE254453T1 (no)
AU (1) AU766202B2 (no)
BG (1) BG65085B1 (no)
BR (1) BR9914418A (no)
CA (1) CA2346335C (no)
CO (1) CO5150213A1 (no)
CZ (1) CZ20011286A3 (no)
DE (1) DE69912978T2 (no)
DK (1) DK1121107T3 (no)
DZ (1) DZ2913A1 (no)
EA (1) EA003990B1 (no)
EE (1) EE04868B1 (no)
EG (1) EG23818A (no)
ES (1) ES2209490T3 (no)
GC (1) GC0000175A (no)
GE (1) GEP20032969B (no)
GT (1) GT199900171A (no)
HK (1) HK1040199B (no)
HR (1) HRP20010263B1 (no)
HU (1) HUP0104470A3 (no)
ID (1) ID29845A (no)
IS (1) IS2239B (no)
MA (1) MA26698A1 (no)
MY (1) MY122477A (no)
NO (1) NO20011829L (no)
NZ (1) NZ510756A (no)
OA (1) OA11662A (no)
PA (1) PA8483301A1 (no)
PE (1) PE20001108A1 (no)
PL (1) PL348119A1 (no)
PT (1) PT1121107E (no)
SK (1) SK4582001A3 (no)
TN (1) TNSN99190A1 (no)
TR (1) TR200101090T2 (no)
TW (1) TWI228043B (no)
UA (1) UA72743C2 (no)
WO (1) WO2000021521A2 (no)
YU (1) YU26401A (no)
ZA (1) ZA200102900B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60026146T2 (de) 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
WO2004065348A1 (en) 2003-01-23 2004-08-05 Pfizer Products Inc. Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof
WO2005000786A1 (en) * 2003-05-23 2005-01-06 Transform Pharmaceuticals, Inc. Sertraline compositions
WO2005034910A1 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Oral liquid pharmaceutical compositions of sertraline
WO2007052152A2 (en) * 2005-11-07 2007-05-10 Aurobindo Pharma Limited Sertraline oral concentrate
WO2008112641A2 (en) * 2007-03-09 2008-09-18 New York University Methods and compositions for treating thalamocortical dysrhythmia
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5130338A (en) * 1989-08-30 1992-07-14 Pfizer Inc. Method of treating chemical dependencies using sertraline
US4940731A (en) * 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
DK0415612T3 (da) * 1989-08-30 1993-12-13 Pfizer Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
US5597826A (en) * 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
SE508372C2 (sv) * 1995-02-13 1998-09-28 Kjell Lindstroem Metod och utrustning för tillförsel eller aspiration av substanser inom gastrointestinalkanalen, avsedd för mätning av farmakokinetiska och fysikalisk-kemiska parametrar
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico
PT980241E (pt) * 1997-07-01 2004-03-31 Pfizer Prod Inc Formas de dosagem encapsuladas em gelatina de sertralina em solucao

Also Published As

Publication number Publication date
ES2209490T3 (es) 2004-06-16
NZ510756A (en) 2003-05-30
DE69912978D1 (de) 2003-12-24
DE69912978T2 (de) 2004-04-22
EE200100221A (et) 2002-08-15
SK4582001A3 (en) 2002-02-05
CN1184962C (zh) 2005-01-19
WO2000021521A2 (en) 2000-04-20
JP2002527385A (ja) 2002-08-27
WO2000021521A3 (en) 2000-07-20
BG105434A (en) 2001-12-29
EP1121107B1 (en) 2003-11-19
HUP0104470A3 (en) 2003-12-29
BR9914418A (pt) 2001-06-26
HK1040199B (zh) 2005-05-27
IS2239B (is) 2007-05-15
ZA200102900B (en) 2002-05-29
AR014082A1 (es) 2001-01-31
AP2001002119A0 (en) 2001-03-22
ID29845A (id) 2001-10-18
HK1040199A1 (en) 2002-05-31
EE04868B1 (et) 2007-08-15
MA26698A1 (fr) 2004-12-20
GT199900171A (es) 2001-03-28
DZ2913A1 (fr) 2004-03-01
PL348119A1 (en) 2002-05-06
GEP20032969B (en) 2003-05-27
CA2346335A1 (en) 2000-04-20
EG23818A (en) 2007-09-19
EP1121107A2 (en) 2001-08-08
HUP0104470A2 (en) 2002-08-28
EA200100285A1 (ru) 2001-10-22
CZ20011286A3 (cs) 2001-09-12
GC0000175A (en) 2006-03-29
EA003990B1 (ru) 2003-12-25
PA8483301A1 (es) 2000-09-29
AU766202B2 (en) 2003-10-09
PT1121107E (pt) 2004-02-27
CO5150213A1 (es) 2002-04-29
HRP20010263A2 (en) 2002-06-30
NO20011829L (no) 2001-06-05
TNSN99190A1 (fr) 2005-11-10
AU5643699A (en) 2000-05-01
OA11662A (en) 2004-12-08
IS5906A (is) 2001-03-23
KR20010080096A (ko) 2001-08-22
YU26401A (sh) 2005-07-19
UA72743C2 (en) 2005-04-15
TR200101090T2 (tr) 2001-12-21
DK1121107T3 (da) 2004-02-23
CA2346335C (en) 2006-04-18
TWI228043B (en) 2005-02-21
NO20011829D0 (no) 2001-04-10
ATE254453T1 (de) 2003-12-15
JP3792514B2 (ja) 2006-07-05
PE20001108A1 (es) 2000-10-26
MY122477A (en) 2006-04-29
CN1323202A (zh) 2001-11-21
BG65085B1 (bg) 2007-02-28
KR100417200B1 (ko) 2004-02-05

Similar Documents

Publication Publication Date Title
EP1020193A4 (en) ORAL PREPARATION
AU141585S (en) Toothbrush
AU138441S (en) Toothbrush
EP1025776A4 (en) TOOTHBRUSH
SI1121112T1 (en) Stable formoterol concentrate
AU136220S (en) Toothbrush
PL346396A1 (en) Preparation agents
GC0000175A (en) Sertraline oral concentrate
SI1121107T1 (en) Sertraline oral concentrate
GB2336524B (en) Toothbrush
AU137388S (en) Toothpick
GB9820349D0 (en) Oral hygiene system
CA83196S (en) Toothbrush
CA85138S (en) Toothbrush
CA85137S (en) Toothbrush
CA83201S (en) Toothbrush
CA83200S (en) Toothbrush
CA83199S (en) Toothbrush
CA83198S (en) Toothbrush
CA83197S (en) Toothbrush
GB9824876D0 (en) Oral composition
GB9810519D0 (en) Oral composition
AU135842S (en) Bib
GB9820265D0 (en) Bib
GB9804956D0 (en) Sectional dental prosthiesis

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20070910

Year of fee payment: 9

PBON Lapse due to non-payment of renewal fee

Effective date: 20080923